Haleon PLC (HLN)
8.45
+0.05
(+0.60%)
USD |
NYSE |
Apr 26, 16:00
8.455
0.00 (0.00%)
Pre-Market: 20:00
Haleon Price: 8.45 for April 26, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 26, 2024 | 8.38 | 8.485 | 8.38 | 8.45 | 2.893M |
| Apr 25, 2024 | 8.32 | 8.42 | 8.31 | 8.40 | 2.270M |
| Apr 24, 2024 | 8.41 | 8.42 | 8.31 | 8.35 | 5.161M |
| Apr 23, 2024 | 8.37 | 8.44 | 8.36 | 8.41 | 3.076M |
| Apr 22, 2024 | 8.22 | 8.365 | 8.20 | 8.36 | 3.991M |
| Apr 19, 2024 | 8.16 | 8.22 | 8.145 | 8.22 | 3.638M |
| Apr 18, 2024 | 8.09 | 8.14 | 8.06 | 8.13 | 4.770M |
| Apr 17, 2024 | 8.08 | 8.12 | 8.04 | 8.11 | 3.621M |
| Apr 16, 2024 | 8.07 | 8.145 | 8.06 | 8.10 | 5.210M |
| Apr 15, 2024 | 8.14 | 8.17 | 8.030 | 8.06 | 4.763M |
| Apr 12, 2024 | 8.14 | 8.17 | 7.99 | 8.01 | 7.844M |
| Apr 11, 2024 | 8.19 | 8.22 | 8.145 | 8.17 | 7.065M |
| Apr 10, 2024 | 8.19 | 8.23 | 8.14 | 8.17 | 4.071M |
| Apr 09, 2024 | 8.28 | 8.30 | 8.22 | 8.29 | 4.365M |
| Apr 08, 2024 | 8.27 | 8.29 | 8.21 | 8.22 | 5.329M |
| Apr 05, 2024 | 8.26 | 8.35 | 8.23 | 8.29 | 6.192M |
| Apr 04, 2024 | 8.30 | 8.36 | 8.22 | 8.23 | 4.001M |
| Apr 03, 2024 | 8.25 | 8.27 | 8.162 | 8.24 | 5.157M |
| Apr 02, 2024 | 8.32 | 8.345 | 8.21 | 8.28 | 8.558M |
| Apr 01, 2024 | 8.46 | 8.485 | 8.325 | 8.34 | 5.890M |
| Mar 28, 2024 | 8.53 | 8.585 | 8.49 | 8.49 | 4.384M |
| Mar 27, 2024 | 8.39 | 8.535 | 8.385 | 8.53 | 5.451M |
| Mar 26, 2024 | 8.41 | 8.43 | 8.335 | 8.41 | 6.488M |
| Mar 25, 2024 | 8.43 | 8.51 | 8.41 | 8.43 | 6.385M |
| Mar 22, 2024 | 8.38 | 8.42 | 8.34 | 8.38 | 8.750M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.63
Minimum
Sep 02 2022
9.00
Maximum
Apr 20 2023
7.857
Average
8.15
Median
Jan 17 2023
Price Benchmarks
| GSK PLC | 41.11 |
| Pfizer Inc | 25.40 |
| AstraZeneca PLC | 75.17 |
| Verona Pharma PLC | 15.47 |
| Adaptimmune Therapeutics PLC | 1.075 |
Price Related Metrics
| PE Ratio | 29.86 |
| PS Ratio | 2.083 |
| Price to Book Value | 1.824 |
| Earnings Yield | 3.35% |
| Market Cap | 38.58B |
| Operating PE Ratio | 11.80 |
| Normalized PE Ratio | 29.86 |